Post-lumpectomy CT-guided tumor bed delineation for breast boost and partial breast irradiation: Can additional pre- and postoperative imaging reduce interobserver variability?

For breast boost radiotherapy or accelerated partial breast irradiation, the tumor bed (TB) is delineated by the radiation oncologist on a planning computed tomography (CT) scan. The aim of the present study was to investigate whether the interobserver variability (IOV) of the TB delineation is redu...

Full description

Saved in:
Bibliographic Details
Published in:Oncology letters Vol. 10; no. 5; pp. 2795 - 2801
Main Authors: DEN HARTOGH, MARISKA D, PHILIPPENS, MARIELLE E.P, VAN DAM, IRIS E, KLEYNEN, CATHARINA E, TERSTEEG, ROBBERT J.H.A, KOTTE, ALEXIS N.T.J, VAN VULPEN, MARCO, VAN ASSELEN, BRAM, VAN DEN BONGARD, DESIRÉE H.J.G
Format: Journal Article
Language:English
Published: Greece D.A. Spandidos 01-11-2015
Spandidos Publications
Spandidos Publications UK Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract For breast boost radiotherapy or accelerated partial breast irradiation, the tumor bed (TB) is delineated by the radiation oncologist on a planning computed tomography (CT) scan. The aim of the present study was to investigate whether the interobserver variability (IOV) of the TB delineation is reduced by providing the radiation oncologist with additional magnetic resonance imaging (MRI) or CT scans. A total of 14 T1-T2 breast cancer patients underwent a standard planning CT in the supine treatment position following lumpectomy, as well as additional pre- and postoperative imaging in the same position. Post-lumpectomy TBs were independently delineated by four breast radiation oncologists on standard postoperative CT and on CT registered to an additional imaging modality. The additional imaging modalities used were postoperative MRI, preoperative contrast-enhanced (CE)-CT and preoperative CE-MRI. A cavity visualization score (CVS) was assigned to each standard postoperative CT by each observer. In addition, the conformity index (CI), volume and distance between centers of mass (dCOM) of the TB delineations were calculated. On CT, the median CI was 0.57, with a median volume of 22 cm3 and dCOM of 5.1 mm. The addition of postoperative MRI increased the median TB volume significantly to 28 cm3 (P<0.001), while the CI (P=0.176) and dCOM (P=0.110) were not affected. The addition of preoperative CT or MRI increased the TB volume to 26 and 25 cm3, respectively (both P<0.001), while the CI increased to 0.58 and 0.59 (both P<0.001) and the dCOM decreased to 4.7 mm (P=0.004) and 4.6 mm (P=0.001), respectively. In patients with CVS≤3, the median CI was 0.40 on CT, which was significantly increased by all additional imaging modalities, up to 0.52, and was accompanied by a median volume increase up to 6 cm3. In conclusion, the addition of postoperative MRI, preoperative CE-CT or preoperative CE-MRI did not result in a considerable reduction in the IOV in postoperative CT-guided TB delineation, while target volumes marginally increased. The value of additional imaging may be dependent on CVS.
AbstractList For breast boost radiotherapy or accelerated partial breast irradiation, the tumor bed (TB) is delineated by the radiation oncologist on a planning computed tomography (CT) scan. The aim of the present study was to investigate whether the interobserver variability (IOV) of the TB delineation is reduced by providing the radiation oncologist with additional magnetic resonance imaging (MRI) or CT scans. A total of 14 T1-T2 breast cancer patients underwent a standard planning CT in the supine treatment position following lumpectomy, as well as additional pre- and postoperative imaging in the same position. Post-lumpectomy TBs were independently delineated by four breast radiation oncologists on standard postoperative CT and on CT registered to an additional imaging modality. The additional imaging modalities used were postoperative MRI, preoperative contrast-enhanced (CE)-CT and preoperative CE-MRI. A cavity visualization score (CVS) was assigned to each standard postoperative CT by each observer. In addition, the conformity index (CI), volume and distance between centers of mass (dCOM) of the TB delineations were calculated. On CT, the median CI was 0.57, with a median volume of 22 cm 3 and dCOM of 5.1 mm. The addition of postoperative MRI increased the median TB volume significantly to 28 cm 3 (P<0.001), while the CI (P=0.176) and dCOM (P=0.110) were not affected. The addition of preoperative CT or MRI increased the TB volume to 26 and 25 cm 3 , respectively (both P<0.001), while the CI increased to 0.58 and 0.59 (both P<0.001) and the dCOM decreased to 4.7 mm (P=0.004) and 4.6 mm (P=0.001), respectively. In patients with CVS≤3, the median CI was 0.40 on CT, which was significantly increased by all additional imaging modalities, up to 0.52, and was accompanied by a median volume increase up to 6 cm 3 . In conclusion, the addition of postoperative MRI, preoperative CE-CT or preoperative CE-MRI did not result in a considerable reduction in the IOV in postoperative CT-guided TB delineation, while target volumes marginally increased. The value of additional imaging may be dependent on CVS.
For breast boost radiotherapy or accelerated partial breast irradiation, the tumor bed (TB) is delineated by the radiation oncologist on a planning computed tomography (CT) scan. The aim of the present study was to investigate whether the interobserver variability (IOV) of the TB delineation is reduced by providing the radiation oncologist with additional magnetic resonance imaging (MRI) or CT scans. A total of 14 T1-T2 breast cancer patients underwent a standard planning CT in the supine treatment position following lumpectomy, as well as additional pre- and postoperative imaging in the same position. Post-lumpectomy TBs were independently delineated by four breast radiation oncologists on standard postoperative CT and on CT registered to an additional imaging modality. The additional imaging modalities used were postoperative MRI, preoperative contrast-enhanced (CE)-CT and preoperative CE-MRI. A cavity visualization score (CVS) was assigned to each standard postoperative CT by each observer. In addition, the conformity index (CI), volume and distance between centers of mass (dCOM) of the TB delineations were calculated. On CT, the median CI was 0.57, with a median volume of 22 cm3 and dCOM of 5.1 mm. The addition of postoperative MRI increased the median TB volume significantly to 28 cm3 (P<0.001), while the CI (P=0.176) and dCOM (P=0.110) were not affected. The addition of preoperative CT or MRI increased the TB volume to 26 and 25 cm3, respectively (both P<0.001), while the CI increased to 0.58 and 0.59 (both P<0.001) and the dCOM decreased to 4.7 mm (P=0.004) and 4.6 mm (P=0.001), respectively. In patients with CVS≤3, the median CI was 0.40 on CT, which was significantly increased by all additional imaging modalities, up to 0.52, and was accompanied by a median volume increase up to 6 cm3. In conclusion, the addition of postoperative MRI, preoperative CE-CT or preoperative CE-MRI did not result in a considerable reduction in the IOV in postoperative CT-guided TB delineation, while target volumes marginally increased. The value of additional imaging may be dependent on CVS.
For breast boost radiotherapy or accelerated partial breast irradiation, the tumor bed (TB) is delineated by the radiation oncologist on a planning computed tomography (CT) scan. The aim of the present study was to investigate whether the interobserver variability (IOV) of the TB delineation is reduced by providing the radiation oncologist with additional magnetic resonance imaging (MRI) or CT scans. A total of 14 T1-T2 breast cancer patients underwent a standard planning CT in the supine treatment position following lumpectomy, as well as additional pre- and postoperative imaging in the same position. Post-lumpectomy TBs were independently delineated by four breast radiation oncologists on standard postoperative CT and on CT registered to an additional imaging modality. The additional imaging modalities used were postoperative MRI, preoperative contrast-enhanced (CE)-CT and preoperative CE-MRI. A cavity visualization score (CVS) was assigned to each standard postoperative CT by each observer. In addition, the conformity index (CI), volume and distance between centers of mass (dCOM) of the TB delineations were calculated. On CT, the median CI was 0.57, with a median volume of 22 cm and dCOM of 5.1 mm. The addition of postoperative MRI increased the median TB volume significantly to 28 cm (P<0.001), while the CI (P=0.176) and dCOM (P=0.110) were not affected. The addition of preoperative CT or MRI increased the TB volume to 26 and 25 cm , respectively (both P<0.001), while the CI increased to 0.58 and 0.59 (both P<0.001) and the dCOM decreased to 4.7 mm (P=0.004) and 4.6 mm (P=0.001), respectively. In patients with CVS≤3, the median CI was 0.40 on CT, which was significantly increased by all additional imaging modalities, up to 0.52, and was accompanied by a median volume increase up to 6 cm . In conclusion, the addition of postoperative MRI, preoperative CE-CT or preoperative CE-MRI did not result in a considerable reduction in the IOV in postoperative CT-guided TB delineation, while target volumes marginally increased. The value of additional imaging may be dependent on CVS.
Audience Academic
Author VAN VULPEN, MARCO
DEN HARTOGH, MARISKA D
PHILIPPENS, MARIELLE E.P
TERSTEEG, ROBBERT J.H.A
KOTTE, ALEXIS N.T.J
VAN DAM, IRIS E
KLEYNEN, CATHARINA E
VAN ASSELEN, BRAM
VAN DEN BONGARD, DESIRÉE H.J.G
AuthorAffiliation Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
AuthorAffiliation_xml – name: Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Author_xml – sequence: 1
  givenname: MARISKA D
  surname: DEN HARTOGH
  fullname: DEN HARTOGH, MARISKA D
  organization: Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
– sequence: 2
  givenname: MARIELLE E.P
  surname: PHILIPPENS
  fullname: PHILIPPENS, MARIELLE E.P
  organization: Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
– sequence: 3
  givenname: IRIS E
  surname: VAN DAM
  fullname: VAN DAM, IRIS E
  organization: Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
– sequence: 4
  givenname: CATHARINA E
  surname: KLEYNEN
  fullname: KLEYNEN, CATHARINA E
  organization: Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
– sequence: 5
  givenname: ROBBERT J.H.A
  surname: TERSTEEG
  fullname: TERSTEEG, ROBBERT J.H.A
  organization: Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
– sequence: 6
  givenname: ALEXIS N.T.J
  surname: KOTTE
  fullname: KOTTE, ALEXIS N.T.J
  organization: Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
– sequence: 7
  givenname: MARCO
  surname: VAN VULPEN
  fullname: VAN VULPEN, MARCO
  organization: Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
– sequence: 8
  givenname: BRAM
  surname: VAN ASSELEN
  fullname: VAN ASSELEN, BRAM
  organization: Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
– sequence: 9
  givenname: DESIRÉE H.J.G
  surname: VAN DEN BONGARD
  fullname: VAN DEN BONGARD, DESIRÉE H.J.G
  organization: Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26722244$$D View this record in MEDLINE/PubMed
BookMark eNptkktv1DAUhSNUREvpjjWyBEIsyOBH4iQsQNWIlzRSWZS15cQ3M64cO7WdkeZf8RNxOu3QQdgLv75zbF2f59mJdRay7CXBC1Y39IMzC4pJuWC8qZ5kZ6RqaE5wTU8O86o4zS5CuMGplZzUNX-WnVJeUUqL4iz7_dOFmJtpGKGLbtih5XW-nrQCheI0OI_aNFNgtAUZtbOon_c8yBBR65IWSavQKH3U0jwcaO-l0nf8R7SUFkml9LxKyOgh32uS2I3gE7YFpAe51naNPKipS0sbwbs2gN-CR1vptWy10XH3-UX2tJcmwMX9eJ79-vrlevk9X119-7G8XOVdyZqYU-CsJKQnrMNlxdqONQVPVeoJhx7Xqm_rlpQK876uFC66uqKEV5L1smiLppHsPPu09x2ndgDVgY1eGjH69FK_E05qcXxi9Uas3VYUnJes4sng3b2Bd7cThCgGHTowRlpwUxCkppwXVUNwQl__g964yadqJaphlLOmJOwvtZYGhLa9S_d2s6m4LFjiMC1pohb_oVJXMOgupafXaf9I8PaRYAPSxE1wZpr_KxyD7_dg510IHvpDMQgWcxqFM2JOo5jTmPBXjwt4gB-yl4A3eyCMKQ9auXBgrlY5Tv3O5w8_H-no
CitedBy_id crossref_primary_10_1016_j_brachy_2020_10_013
crossref_primary_10_1186_s12885_017_3144_5
crossref_primary_10_1016_j_adro_2021_100848
crossref_primary_10_1007_s00330_020_07085_0
crossref_primary_10_1016_j_ctro_2022_100564
crossref_primary_10_1186_s13014_021_01817_2
crossref_primary_10_4329_wjr_v12_i5_68
crossref_primary_10_1016_j_radonc_2021_11_001
crossref_primary_10_1515_raon_2017_0014
crossref_primary_10_3390_cancers16112122
crossref_primary_10_3389_fonc_2020_01107
Cites_doi 10.1016/j.ejca.2008.07.032
10.1148/radiology.219.1.r01ap34203
10.1016/j.ijrobp.2011.05.008
10.1097/COC.0b013e3182467ffd
10.1016/S0167-8140(00)00210-3
10.1016/j.radonc.2010.01.009
10.1245/s10434-014-3801-8
10.1016/j.ejso.2008.09.005
10.1016/j.ejso.2012.05.008
10.1016/j.cmpb.2009.04.008
10.1200/JCO.2007.11.4991
10.1016/j.radonc.2011.12.021
10.1016/j.radonc.2005.03.029
10.1007/s10549-011-1696-7
10.1148/radiology.153.1.6089263
10.1016/j.radonc.2013.10.033
10.1016/j.ijrobp.2007.12.021
10.1016/j.radonc.2013.02.003
10.1016/j.radonc.2010.07.025
10.1016/j.ijrobp.2009.02.028
10.1016/j.radonc.2011.08.024
10.1186/1748-717X-9-63
10.1016/j.radonc.2007.12.001
10.3109/0284186X.2013.861924
10.1016/j.ijrobp.2010.09.041
10.1016/S0140-6736(11)61629-2
10.1016/j.ijrobp.2006.11.026
ContentType Journal Article
Copyright Copyright: © Den Hartogh et al.
COPYRIGHT 2015 Spandidos Publications
Copyright Spandidos Publications UK Ltd. 2015
Copyright: © Den Hartogh et al. 2015
Copyright_xml – notice: Copyright: © Den Hartogh et al.
– notice: COPYRIGHT 2015 Spandidos Publications
– notice: Copyright Spandidos Publications UK Ltd. 2015
– notice: Copyright: © Den Hartogh et al. 2015
DBID NPM
AAYXX
CITATION
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.3892/ol.2015.3697
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
British Nursing Database
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
British Nursing Index with Full Text
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest One Academic Eastern Edition

PubMed
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1792-1082
EndPage 2801
ExternalDocumentID A439320252
10_3892_ol_2015_3697
26722244
OL-0-0-3697
Genre Journal Article
GroupedDBID -
0R
3V.
53G
7X7
8FI
8FJ
AAKDD
AAPBV
AASXA
ABDBF
ABPTK
ABUWG
ACGFS
ADBBV
AENEX
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AN0
BBAFP
BENPR
BNQBC
BPHCQ
BVXVI
C45
EBD
EBS
EJD
ESX
F5P
FYUFA
H13
HUR
HZ
IAO
IHR
IHW
ITC
O9-
OK1
OVD
PQEST
PQQKQ
PQUKI
PRINS
PROAC
RIG
W2D
---
0R~
ABJNI
ALIPV
CCPQU
HMCUK
HZ~
IPNFZ
NPM
RPM
TEORI
UKHRP
AAYXX
CITATION
7XB
8FK
K9.
7X8
5PM
ID FETCH-LOGICAL-c539t-2e63511f13c0573bc3946369f16ef08dfb8b15d06f87d04c872167a3fa4b499a3
IEDL.DBID RPM
ISSN 1792-1074
IngestDate Tue Sep 17 20:35:47 EDT 2024
Fri Oct 25 08:10:43 EDT 2024
Thu Oct 10 19:00:46 EDT 2024
Tue Nov 19 20:46:00 EST 2024
Tue Nov 12 22:47:04 EST 2024
Tue Aug 20 22:13:08 EDT 2024
Fri Aug 23 03:19:38 EDT 2024
Sat Sep 28 07:58:41 EDT 2024
Tue Jan 05 23:28:30 EST 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords radiotherapy
magnetic resonance imaging
tumor bed
interobserver variability
breast-conserving therapy
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c539t-2e63511f13c0573bc3946369f16ef08dfb8b15d06f87d04c872167a3fa4b499a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665376/
PMID 26722244
PQID 1932639513
PQPubID 2044954
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4665376
proquest_miscellaneous_1826647910
proquest_journals_1932639513
gale_infotracmisc_A439320252
gale_infotracacademiconefile_A439320252
gale_healthsolutions_A439320252
crossref_primary_10_3892_ol_2015_3697
pubmed_primary_26722244
spandidos_primary_OL-0-0-3697
PublicationCentury 2000
PublicationDate 2015-11-01
PublicationDateYYYYMMDD 2015-11-01
PublicationDate_xml – month: 11
  year: 2015
  text: 2015-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Greece
PublicationPlace_xml – name: Greece
– name: Athens
PublicationTitle Oncology letters
PublicationTitleAlternate Oncol Lett
PublicationYear 2015
Publisher D.A. Spandidos
Spandidos Publications
Spandidos Publications UK Ltd
Publisher_xml – name: D.A. Spandidos
– name: Spandidos Publications
– name: Spandidos Publications UK Ltd
References Schmitz, van den Bosch, Loo, Mali, Bartelink, Gertenbach, Holland, Peterse, Rutgers, Gilhuijs (b28-ol-0-0-3697) 2010; 97
Boersma, Janssen, Elkhuizen, Poortmans, van der Sangen, Scholten, Hanbeukers, Duppen, Hurkmans, van Vliet (b14-ol-0-0-3697) 2012; 103
Smitt, Birdwell, Goffinet (b19-ol-0-0-3697) 2001; 219
Mukesh, Barnett, Cumming, Wilkinson, Moody, Wilson, Wishart, Coles (b12-ol-0-0-3697) 2012; 38
Dixon (b17-ol-0-0-3697) 1984; 153
den Hartogh, Philippens, van Dam (b15-ol-0-0-3697) 2014; 9
Collette, Collette, Budiharto (b10-ol-0-0-3697) 2008; 44
Vrieling, Collette, Fourquet (b11-ol-0-0-3697) 2000; 55
Hurkmans, Admiraal, van der Sangen, Dijkmans (b6-ol-0-0-3697) 2009; 90
den Hartogh, van Asselen, Monninkhof (b9-ol-0-0-3697) 2011; 129
Kirby, Jena, Harris, Evans, Crowley, Gregory, Coles (b24-ol-0-0-3697) 2013; 106
Jolicoeur, Racine, Trop, Hathout, Nguyen, Derashodian, David (b23-ol-0-0-3697) 2011; 100
Malinen, Muren (b3-ol-0-0-3697) 2014; 53
Giezen, Kouwenhoven, Scholten, Coerkamp, Heijenbrok, Jansen, Mast, Petoukhova, Struikmans (b22-ol-0-0-3697) 2012; 82
Nichols, Feigenberg, Marter, Cheston, Lasio, Tkaczuk, Kesmodel, Buras, Regine (b26-ol-0-0-3697) 2013; 36
Coles, Wilson, Cumming, Benson, Forouhi, Wilkinson, Jena, Wishart (b5-ol-0-0-3697) 2009; 35
den Hartogh, van den Bongard, Davidson, Kotte, Verkooijen, Philippens, van Vulpen, van Asselen, Pignol (b21-ol-0-0-3697) 2014; 21
van Mourik, Elkhuizen, Minkema, Duppen, van Vliet-Vroegindeweij (b7-ol-0-0-3697) 2010; 94
Landis, Luo, Song, Bellon, Punglia, Wong, Killoran, Gelman, Harris (b8-ol-0-0-3697) 2007; 67
Kirby, Yarnold, Evans, Morgan, Schmidt, Scurr, desouza (b20-ol-0-0-3697) 2009; 74
Bol, Kotte, van der Heide, Lagendijk (b18-ol-0-0-3697) 2009; 96
Palta, Yoo, Adamson, Prosnitz, Horton (b25-ol-0-0-3697) 2012; 82
Struikmans, Wárlám-Rodenhuis, Stam, Stapper, Tersteeg, Bol, Raaijmakers (b4-ol-0-0-3697) 2005; 76
Bartelink, Horiot, Poortmans (b2-ol-0-0-3697) 2007; 25
Darby, McGale, Correa (b1-ol-0-0-3697) 2011; 378
den Hartogh (b29-ol-0-0-3697) 2014
(b16-ol-0-0-3697) 2009
Whipp, Halliwell (b13-ol-0-0-3697) 2008; 72
van der Leij, Elkhuizen, Janssen, Poortmans, van der Sangen, Scholten, van Vliet-Vroegindeweij, Boersma (b27-ol-0-0-3697) 2014; 110
17577015 - J Clin Oncol. 2007 Aug 1;25(22):3259-65
18440725 - Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):49-57
18207594 - Radiother Oncol. 2009 Jan;90(1):60-5
18938055 - Eur J Surg Oncol. 2009 Jun;35(6):578-82
20199818 - Radiother Oncol. 2010 Mar;94(3):286-91
18757193 - Eur J Cancer. 2008 Nov;44(17):2587-99
22265730 - Radiother Oncol. 2012 May;103(2):178-82
19464816 - Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1276-82
22704052 - Eur J Surg Oncol. 2012 Oct;38(10):918-24
21822639 - Breast Cancer Res Treat. 2011 Oct;129(3):857-65
17275202 - Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1299-308
24262820 - Radiother Oncol. 2014 Mar;110(3):467-70
21708426 - Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1332-40
24286539 - Acta Oncol. 2014 Jan;53(1):3-5
16165237 - Radiother Oncol. 2005 Sep;76(3):293-9
21093166 - Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):37-42
20826026 - Radiother Oncol. 2010 Nov;97(2):225-32
6089263 - Radiology. 1984 Oct;153(1):189-94
22549267 - Am J Clin Oncol. 2013 Jun;36(3):232-8
11274557 - Radiology. 2001 Apr;219(1):203-6
21924509 - Radiother Oncol. 2011 Sep;100(3):480-4
23490269 - Radiother Oncol. 2013 Feb;106(2):231-5
19443076 - Comput Methods Programs Biomed. 2009 Nov;96(2):133-40
22019144 - Lancet. 2011 Nov 12;378(9804):1707-16
24571783 - Radiat Oncol. 2014 Feb 26;9:63
24874499 - Ann Surg Oncol. 2014 Nov;21(12):3774-9
10869738 - Radiother Oncol. 2000 Jun;55(3):219-32
Struikmans (key20180108100700_b4-ol-0-0-3697) 2005; 76
den Hartogh (key20180108100700_b9-ol-0-0-3697) 2011; 129
Collette (key20180108100700_b10-ol-0-0-3697) 2008; 44
Smitt (key20180108100700_b19-ol-0-0-3697) 2001; 219
Schmitz (key20180108100700_b28-ol-0-0-3697) 2010; 97
Bol (key20180108100700_b18-ol-0-0-3697) 2009; 96
Malinen (key20180108100700_b3-ol-0-0-3697) 2014; 53
Vrieling (key20180108100700_b11-ol-0-0-3697) 2000; 55
Darby (key20180108100700_b1-ol-0-0-3697) 2011; 378
Sobin (key20180108100700_b16-ol-0-0-3697) 2009
den Hartogh (key20180108100700_b29-ol-0-0-3697) 2014
den Hartogh (key20180108100700_b21-ol-0-0-3697) 2014; 21
Kirby (key20180108100700_b20-ol-0-0-3697) 2009; 74
Boersma (key20180108100700_b14-ol-0-0-3697) 2012; 103
Bartelink (key20180108100700_b2-ol-0-0-3697) 2007; 25
Whipp (key20180108100700_b13-ol-0-0-3697) 2008; 72
Dixon (key20180108100700_b17-ol-0-0-3697) 1984; 153
Hurkmans (key20180108100700_b6-ol-0-0-3697) 2009; 90
van Mourik (key20180108100700_b7-ol-0-0-3697) 2010; 94
Coles (key20180108100700_b5-ol-0-0-3697) 2009; 35
Kirby (key20180108100700_b24-ol-0-0-3697) 2013; 106
Landis (key20180108100700_b8-ol-0-0-3697) 2007; 67
Giezen (key20180108100700_b22-ol-0-0-3697) 2012; 82
Nichols (key20180108100700_b26-ol-0-0-3697) 2013; 36
den Hartogh (key20180108100700_b15-ol-0-0-3697) 2014; 9
Jolicoeur (key20180108100700_b23-ol-0-0-3697) 2011; 100
van der Leij (key20180108100700_b27-ol-0-0-3697) 2014; 110
Palta (key20180108100700_b25-ol-0-0-3697) 2012; 82
Mukesh (key20180108100700_b12-ol-0-0-3697) 2012; 38
References_xml – volume: 90
  start-page: 60
  year: 2009
  end-page: 65
  ident: b6-ol-0-0-3697
  article-title: Significance of breast boost volume changes during radiotherapy in relation to current clinical interobserver variations
  publication-title: Radiother Oncol
  contributor:
    fullname: Dijkmans
– volume: 44
  start-page: 2587
  year: 2008
  end-page: 2599
  ident: b10-ol-0-0-3697
  article-title: EORTC Radiation Oncology Group: Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: A study based on the EORTC Trial 22881-10882 'boost versus no boost'
  publication-title: Eur J Cancer
  contributor:
    fullname: Budiharto
– volume: 96
  start-page: 133
  year: 2009
  end-page: 140
  ident: b18-ol-0-0-3697
  article-title: Simultaneous multi-modality ROI delineation in clinical practice
  publication-title: Comput Methods Programs Biomed
  contributor:
    fullname: Lagendijk
– volume: 94
  start-page: 286
  year: 2010
  end-page: 291
  ident: b7-ol-0-0-3697
  article-title: Dutch Young Boost Study Group: Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines
  publication-title: Radiother Oncol
  contributor:
    fullname: van Vliet-Vroegindeweij
– volume: 21
  start-page: 3774
  year: 2014
  end-page: 3779
  ident: b21-ol-0-0-3697
  article-title: Full-thickness closure in breast-conserving surgery: The impact on radiotherapy target definition for boost and partial breast irradiation. A multimodality image evaluation
  publication-title: Ann Surg Oncol
  contributor:
    fullname: Pignol
– volume: 9
  start-page: 63
  year: 2014
  ident: b15-ol-0-0-3697
  article-title: MRI and CT imaging for preoperative target volume delineation in breast-conserving therapy
  publication-title: Radiat Oncol
  contributor:
    fullname: van Dam
– volume: 82
  start-page: 37
  year: 2012
  end-page: 42
  ident: b25-ol-0-0-3697
  article-title: Preoperative single fraction partial breast radiotherapy for early-stage breast cancer
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Horton
– volume: 129
  start-page: 857
  year: 2011
  end-page: 1865
  ident: b9-ol-0-0-3697
  article-title: Excised and irradiated volumes in relation to the tumor size in breast-conserving therapy
  publication-title: Breast Cancer Res Treat
  contributor:
    fullname: Monninkhof
– volume: 153
  start-page: 189
  year: 1984
  end-page: 194
  ident: b17-ol-0-0-3697
  article-title: Simple proton spectroscopic imaging
  publication-title: Radiology
  contributor:
    fullname: Dixon
– volume: 55
  start-page: 219
  year: 2000
  end-page: 232
  ident: b11-ol-0-0-3697
  article-title: EORTC Radiotherapy and Breast Cancer Cooperative Groups: The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial
  publication-title: Radiother Oncol
  contributor:
    fullname: Fourquet
– volume: 100
  start-page: 480
  year: 2011
  end-page: 484
  ident: b23-ol-0-0-3697
  article-title: Localization of the surgical bed using supine magnetic resonance and computed tomography scan fusion for planification of breast interstitial brachytherapy
  publication-title: Radiother Oncol
  contributor:
    fullname: David
– volume: 103
  start-page: 178
  year: 2012
  end-page: 182
  ident: b14-ol-0-0-3697
  article-title: Reducing interobserver variation of boost-CTV delineation in breast conserving radiation therapy using a pre-operative CT and delineation guidelines
  publication-title: Radiother Oncol
  contributor:
    fullname: van Vliet
– volume: 67
  start-page: 1299
  year: 2007
  end-page: 1308
  ident: b8-ol-0-0-3697
  article-title: Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Harris
– volume: 110
  start-page: 467
  year: 2014
  end-page: 470
  ident: b27-ol-0-0-3697
  article-title: Target volume delineation in external beam partial breast irradiation: Less inter-observer variation with preoperative-compared to postoperative delineation
  publication-title: Radiother Oncol
  contributor:
    fullname: Boersma
– volume: 76
  start-page: 293
  year: 2005
  end-page: 299
  ident: b4-ol-0-0-3697
  article-title: Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation
  publication-title: Radiother Oncol
  contributor:
    fullname: Raaijmakers
– volume: 53
  start-page: 3
  year: 2014
  end-page: 5
  ident: b3-ol-0-0-3697
  article-title: Image guided therapy - do we get the picture?
  publication-title: Acta Oncol
  contributor:
    fullname: Muren
– volume: 38
  start-page: 918
  year: 2012
  end-page: 924
  ident: b12-ol-0-0-3697
  article-title: Association of breast tumour bed seroma with post-operative complications and late normal tissue toxicity: Results from the Cambridge Breast IMRT trial
  publication-title: Eur J Surg Oncol
  contributor:
    fullname: Coles
– volume: 72
  start-page: 49
  year: 2008
  end-page: 57
  ident: b13-ol-0-0-3697
  article-title: Magnetic resonance imaging appearances in the postoperative breast: The clinical target volume-tumor and its relationship to the chest wall
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Halliwell
– volume: 106
  start-page: 231
  year: 2013
  end-page: 235
  ident: b24-ol-0-0-3697
  article-title: Tumour bed delineation for partial breast/breast boost radiotherapy: What is the optimal number of implanted markers?
  publication-title: Radiother Oncol
  contributor:
    fullname: Coles
– volume: 97
  start-page: 225
  year: 2010
  end-page: 232
  ident: b28-ol-0-0-3697
  article-title: Precise correlation between MRI and histopathology - exploring treatment margins for MRI-guided localized breast cancer therapy
  publication-title: Radiother Oncol
  contributor:
    fullname: Gilhuijs
– volume: 25
  start-page: 3259
  year: 2007
  end-page: 3265
  ident: b2-ol-0-0-3697
  article-title: Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial
  publication-title: J Clin Oncol
  contributor:
    fullname: Poortmans
– volume: 378
  start-page: 1707
  year: 2011
  end-page: 1716
  ident: b1-ol-0-0-3697
  article-title: Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials
  publication-title: Lancet
  contributor:
    fullname: Correa
– volume: 36
  start-page: 232
  year: 2013
  end-page: 238
  ident: b26-ol-0-0-3697
  article-title: Preoperative radiation therapy significantly increases patient eligibility for accelerated partial breast irradiation using 3D-conformal radiotherapy
  publication-title: Am J Clin Oncol
  contributor:
    fullname: Regine
– year: 2014
  ident: b29-ol-0-0-3697
  article-title: Towards MRI-guided radiotherapy in early-stage breast cancer patients
  contributor:
    fullname: den Hartogh
– year: 2009
  ident: b16-ol-0-0-3697
  publication-title: International Union Against Cancer (UICC): TNM Classification of Malignant Tumors
– volume: 35
  start-page: 578
  year: 2009
  end-page: 582
  ident: b5-ol-0-0-3697
  article-title: Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery: Audit on behalf of the IMPORT Trial Management Group
  publication-title: Eur J Surg Oncol
  contributor:
    fullname: Wishart
– volume: 74
  start-page: 1276
  year: 2009
  end-page: 1282
  ident: b20-ol-0-0-3697
  article-title: Tumor bed delineation for partial breast and breast boost radiotherapy planned in the prone position: What does MRI add to X-ray CT localization of titanium clips placed in the excision cavity wall?
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: desouza
– volume: 219
  start-page: 203
  year: 2001
  end-page: 206
  ident: b19-ol-0-0-3697
  article-title: Breast electron boost planning: Comparison of CT and US
  publication-title: Radiology
  contributor:
    fullname: Goffinet
– volume: 82
  start-page: 1332
  year: 2012
  end-page: 1340
  ident: b22-ol-0-0-3697
  article-title: MRI-versus CT-based volume delineation of lumpectomy cavity in supine position in breast-conserving therapy: An exploratory study
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Struikmans
– volume: 44
  start-page: 2587
  year: 2008
  ident: key20180108100700_b10-ol-0-0-3697
  article-title: EORTC Radiation Oncology Group: Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: A study based on the EORTC Trial 22881-10882 ‘boost versus no boost’
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2008.07.032
  contributor:
    fullname: Collette
– volume: 219
  start-page: 203
  year: 2001
  ident: key20180108100700_b19-ol-0-0-3697
  article-title: Breast electron boost planning: Comparison of CT and US
  publication-title: Radiology
  doi: 10.1148/radiology.219.1.r01ap34203
  contributor:
    fullname: Smitt
– volume: 82
  start-page: 1332
  year: 2012
  ident: key20180108100700_b22-ol-0-0-3697
  article-title: MRI-versus CT-based volume delineation of lumpectomy cavity in supine position in breast-conserving therapy: An exploratory study
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2011.05.008
  contributor:
    fullname: Giezen
– volume: 36
  start-page: 232
  year: 2013
  ident: key20180108100700_b26-ol-0-0-3697
  article-title: Preoperative radiation therapy significantly increases patient eligibility for accelerated partial breast irradiation using 3D-conformal radiotherapy
  publication-title: Am J Clin Oncol
  doi: 10.1097/COC.0b013e3182467ffd
  contributor:
    fullname: Nichols
– volume: 55
  start-page: 219
  year: 2000
  ident: key20180108100700_b11-ol-0-0-3697
  article-title: EORTC Radiotherapy and Breast Cancer Cooperative Groups: The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial
  publication-title: Radiother Oncol
  doi: 10.1016/S0167-8140(00)00210-3
  contributor:
    fullname: Vrieling
– year: 2009
  ident: key20180108100700_b16-ol-0-0-3697
  publication-title: International Union Against Cancer (UICC): TNM Classification of Malignant Tumors
  contributor:
    fullname: Sobin
– volume: 94
  start-page: 286
  year: 2010
  ident: key20180108100700_b7-ol-0-0-3697
  article-title: Dutch Young Boost Study Group: Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2010.01.009
  contributor:
    fullname: van Mourik
– volume: 21
  start-page: 3774
  year: 2014
  ident: key20180108100700_b21-ol-0-0-3697
  article-title: Full-thickness closure in breast-conserving surgery: The impact on radiotherapy target definition for boost and partial breast irradiation. A multimodality image evaluation
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-014-3801-8
  contributor:
    fullname: den Hartogh
– volume: 35
  start-page: 578
  year: 2009
  ident: key20180108100700_b5-ol-0-0-3697
  article-title: Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery: Audit on behalf of the IMPORT Trial Management Group
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2008.09.005
  contributor:
    fullname: Coles
– volume: 38
  start-page: 918
  year: 2012
  ident: key20180108100700_b12-ol-0-0-3697
  article-title: Association of breast tumour bed seroma with post-operative complications and late normal tissue toxicity: Results from the Cambridge Breast IMRT trial
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2012.05.008
  contributor:
    fullname: Mukesh
– volume: 96
  start-page: 133
  year: 2009
  ident: key20180108100700_b18-ol-0-0-3697
  article-title: Simultaneous multi-modality ROI delineation in clinical practice
  publication-title: Comput Methods Programs Biomed
  doi: 10.1016/j.cmpb.2009.04.008
  contributor:
    fullname: Bol
– volume: 25
  start-page: 3259
  year: 2007
  ident: key20180108100700_b2-ol-0-0-3697
  article-title: Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.11.4991
  contributor:
    fullname: Bartelink
– volume: 103
  start-page: 178
  year: 2012
  ident: key20180108100700_b14-ol-0-0-3697
  article-title: Reducing interobserver variation of boost-CTV delineation in breast conserving radiation therapy using a pre-operative CT and delineation guidelines
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2011.12.021
  contributor:
    fullname: Boersma
– volume: 76
  start-page: 293
  year: 2005
  ident: key20180108100700_b4-ol-0-0-3697
  article-title: Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2005.03.029
  contributor:
    fullname: Struikmans
– volume: 129
  start-page: 857
  year: 2011
  ident: key20180108100700_b9-ol-0-0-3697
  article-title: Excised and irradiated volumes in relation to the tumor size in breast-conserving therapy
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-011-1696-7
  contributor:
    fullname: den Hartogh
– volume: 153
  start-page: 189
  year: 1984
  ident: key20180108100700_b17-ol-0-0-3697
  article-title: Simple proton spectroscopic imaging
  publication-title: Radiology
  doi: 10.1148/radiology.153.1.6089263
  contributor:
    fullname: Dixon
– volume: 110
  start-page: 467
  year: 2014
  ident: key20180108100700_b27-ol-0-0-3697
  article-title: Target volume delineation in external beam partial breast irradiation: Less inter-observer variation with preoperative-compared to postoperative delineation
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2013.10.033
  contributor:
    fullname: van der Leij
– volume: 72
  start-page: 49
  year: 2008
  ident: key20180108100700_b13-ol-0-0-3697
  article-title: Magnetic resonance imaging appearances in the postoperative breast: The clinical target volume-tumor and its relationship to the chest wall
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2007.12.021
  contributor:
    fullname: Whipp
– volume: 106
  start-page: 231
  year: 2013
  ident: key20180108100700_b24-ol-0-0-3697
  article-title: Tumour bed delineation for partial breast/breast boost radiotherapy: What is the optimal number of implanted markers?
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2013.02.003
  contributor:
    fullname: Kirby
– volume: 97
  start-page: 225
  year: 2010
  ident: key20180108100700_b28-ol-0-0-3697
  article-title: Precise correlation between MRI and histopathology - exploring treatment margins for MRI-guided localized breast cancer therapy
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2010.07.025
  contributor:
    fullname: Schmitz
– volume: 74
  start-page: 1276
  year: 2009
  ident: key20180108100700_b20-ol-0-0-3697
  article-title: Tumor bed delineation for partial breast and breast boost radiotherapy planned in the prone position: What does MRI add to X-ray CT localization of titanium clips placed in the excision cavity wall?
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2009.02.028
  contributor:
    fullname: Kirby
– volume: 100
  start-page: 480
  year: 2011
  ident: key20180108100700_b23-ol-0-0-3697
  article-title: Localization of the surgical bed using supine magnetic resonance and computed tomography scan fusion for planification of breast interstitial brachytherapy
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2011.08.024
  contributor:
    fullname: Jolicoeur
– volume: 9
  start-page: 63
  year: 2014
  ident: key20180108100700_b15-ol-0-0-3697
  article-title: MRI and CT imaging for preoperative target volume delineation in breast-conserving therapy
  publication-title: Radiat Oncol
  doi: 10.1186/1748-717X-9-63
  contributor:
    fullname: den Hartogh
– year: 2014
  ident: key20180108100700_b29-ol-0-0-3697
  article-title: Towards MRI-guided radiotherapy in early-stage breast cancer patients
  contributor:
    fullname: den Hartogh
– volume: 90
  start-page: 60
  year: 2009
  ident: key20180108100700_b6-ol-0-0-3697
  article-title: Significance of breast boost volume changes during radiotherapy in relation to current clinical interobserver variations
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2007.12.001
  contributor:
    fullname: Hurkmans
– volume: 53
  start-page: 3
  year: 2014
  ident: key20180108100700_b3-ol-0-0-3697
  article-title: Image guided therapy - do we get the picture?
  publication-title: Acta Oncol
  doi: 10.3109/0284186X.2013.861924
  contributor:
    fullname: Malinen
– volume: 82
  start-page: 37
  year: 2012
  ident: key20180108100700_b25-ol-0-0-3697
  article-title: Preoperative single fraction partial breast radiotherapy for early-stage breast cancer
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2010.09.041
  contributor:
    fullname: Palta
– volume: 378
  start-page: 1707
  year: 2011
  ident: key20180108100700_b1-ol-0-0-3697
  article-title: Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)61629-2
  contributor:
    fullname: Darby
– volume: 67
  start-page: 1299
  year: 2007
  ident: key20180108100700_b8-ol-0-0-3697
  article-title: Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2006.11.026
  contributor:
    fullname: Landis
SSID ssj0000561886
Score 2.1301222
Snippet For breast boost radiotherapy or accelerated partial breast irradiation, the tumor bed (TB) is delineated by the radiation oncologist on a planning computed...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
spandidos
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 2795
SubjectTerms Breast cancer
breast-conserving therapy
Care and treatment
CT imaging
interobserver variability
Lumpectomy
magnetic resonance imaging
Mastectomy
Medical imaging
Methods
NMR
Nuclear magnetic resonance
Oncology
Patient outcomes
radiotherapy
Tomography
tumor bed
Title Post-lumpectomy CT-guided tumor bed delineation for breast boost and partial breast irradiation: Can additional pre- and postoperative imaging reduce interobserver variability?
URI https://www.ncbi.nlm.nih.gov/pubmed/26722244
https://www.proquest.com/docview/1932639513
https://search.proquest.com/docview/1826647910
https://pubmed.ncbi.nlm.nih.gov/PMC4665376
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELboHoAL4k1gF4wE4uTWTRwn4YJWZVccWEBikbhF8QsibZIqbZD2X_ETmYmTqNkjl6qNx07qmfGM45lvCHljUm6UEJrZMNZMhFazNHWcaR0huDqiFvWlE74nX36mH88QJicec2H6oH2tymV9VS3r8ncfW7mt9GqME1t9u9gIKRGFZLUgC_AND7boHtBbrtO-wiPIWsgw4NAHvINpDlcNHjes42UkM6y_F8oEDKQQM6t0c20-ME43AyfvgNrXpjTN7sAqnd8n9wZ3kp76x35Abtn6Ibl9MRyYPyJ_sRgvgwUIEyqb6ppuLtmvrjTW0H1XNS1V8M1gTrr3HanDaxiovqfgf8Mn3JhucVrgNkND2baIaID07-mmqCkGJfl3ihSjSnwfROzYWg8sTsuqr4ZEW0SKhZ_IzkbhG2Hb0j-wX_dw4dcfHpMf52eXm09sKNLAdBxlexZaiWeRbh1pxFZUOsoQgyxza2kdT41TqVrHhkuXJoYLnSJaUFJErhAKdltF9IQc1U1tnxFqFIykYaCQK-GSAtY_y3UWW25daCQPyNuRSfnWY3HksIdBvubNVY58zZGvAXmFHMx9JumkwvkpOF9YLj4OA_Kup0AlBkbqYshFgOdAOKwZ5fGMEpRPz5tHKckH5d_lvU8cgesaBeT11Iw9MaCttk0HNLCtkyIBZy0gT71QTf9pFMqAJDNxmwgQEnzeAprSQ4MPmhGQk0kwp15fPzOOYMowQ8__e-QX5C7Os8_GPCZH-7azJ2SxM93LXg3_AQW7OL0
link.rule.ids 230,315,729,782,786,887,27935,27936,53803,53805
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB7RItFeeEMNLV0kEKdN1m-bC6pCqyKSgkSQuFn27hos1XbkxEj9V_xEZryOFffYS5RkZ9evb3ZnvDPfALxTkVCZ50muHV9yz9GSR1EuuJQukasTa1FXOuFHePUr-nxONDn-NhemC9qXWTGprstJVfzpYitXpZxu48Sm3xczLwiIhWS6B_dRX4W746QbSu_Ajroaj4g2h1PIoQl5x8XZmda04WD7EzeIqQKfE4S4RHreaF26PTvvLE-3QycPUPErVah6vbMuXTy64xU9hoe9IcrOTPMTuKerp_Bg0W-1P4N_VMaX49RFqZh1ecNmS_67LZRWbNOWdcMy_KYom91YnSyn_yjEfcPQcsdPPGG2osPjYfqGommIC4HkP7JZWjEKZzJvIxnFo5g-xPWx0oaSnBVlV0eJNcQxiz8JCHVG75J1w_6ip2-Ixm8-PYefF-fL2SXvyztw6bvxhjs6oF3M3HYlsTJm0o2JvSzO7UDnIlJ5FmW2r0SQR6ESnoyIZyhM3Tz1MvTTUvcF7Fd1pY-AqQxHkjiQIzIvD1OcObWQsa-Fzh0VCAvebx9usjIsHgl6P4SHpL5OCA8J4cGCU3ryiclBHZQ_OUOzjQrN-44FHzoJUn8EgEz7LAY8DyLSGkkejyRRbeW4eYuupJ821klnTbto9LoWvB2aqSeFwlW6blEGHcLAC9HMs-ClAeNwTVswWxCOYDoIEJn4uAUR2ZGK9wi04GQA9NDr25wLomHGO_TqziOfwsHlcjFP5l-uvr6GQ7rnJqfzGPY3TatPYG-t2jedKv8HHDJOTQ
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RIhUuvAuBlhoJxMm73rzDBVXbrkC0pRJF4hYlfkCkbhJlN0j9V_xEZuJstOkRLtFmPXac5PPMOB5_A_BWxULlvi-5dgPJfVdLHsdGcCk9Ilcn1qIudcK36OJHfHJKNDlDqq8uaF_mxaS8Xk7K4lcXW1kv5XQTJza9PJ_7YUgsJNNamekO3MUxK4Ktibql9Q5ncZfnERHncgo7tGHvaKDdaUWLDrNg4oUJZeFzwwjNpO-PbNNtDb1lom6HT97DwV-qQlWrLdu0ePgfd_UIHvQOKTu2Io_hji6fwN55v-T-FP5QOl-OKoy2ZFbLGza_4j_bQmnF1u2yaliOvxTtarfeJzP0H4W6rxl68HjETrOauoCX6QuKpiFOBJL_wOZZySisyX6VZBSXYusQ50etLTU5K5ZdPiXWENcsnhIgqpy-KeuG_cYZvyUcv_n4DL4vTq_mn3if5oHLwEvW3NUhrWaamSeJnTGXXkIsZomZhdqIWJk8zmeBEqGJIyV8GRPfUJR5JvNznK9l3j7sllWpXwBTObYksSFX5L6JMtSgWsgk0EIbV4XCgXebF5zWls0jxVkQYSKtrlPCREqYcOCI3n5q96IOSiA9RveNEs4HrgPvOwlSAwgCmfW7GbAfRKg1kjwYSeLwlePiDcLSXn2s0s6r9tD59Rx4MxRTTQqJK3XVogxODEM_QnfPgecWkMM9bQDtQDSC6iBApOLjEkRlRy7eo9CBwwHUQ62vZ1wQHTM-oZf_3PIR7F2eLNKzzxdfXsF9euR2a-cB7K6bVh_Czkq1r7vR_BdyQFDN
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Post-lumpectomy+CT-guided+tumor+bed+delineation+for+breast+boost+and+partial+breast+irradiation%3A+Can+additional+pre-+and+postoperative+imaging+reduce+interobserver+variability%3F&rft.jtitle=Oncology+letters&rft.au=DEN+Hartogh%2C+Mariska+D&rft.au=Philippens%2C+Marielle+E+P&rft.au=VAN+Dam%2C+Iris+E&rft.au=Kleynen%2C+Catharina+E&rft.date=2015-11-01&rft.issn=1792-1074&rft.volume=10&rft.issue=5&rft.spage=2795&rft.epage=2801&rft_id=info:doi/10.3892%2Fol.2015.3697&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1792-1074&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1792-1074&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1792-1074&client=summon